MedPath

MYocardial DOmmages Related to COVID-19

Completed
Conditions
Myocarditis
Covid19
Non Ischemic Myocardial Injury
Myocardial Infarction
Troponin Elevation
Interventions
Biological: Biological data
Other: Clinical data
Registration Number
NCT04498065
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Brief Summary

Myocardial injury, as assessed by elevation of cardiac troponins (Tnc), is frequent among patients with COVID-19. Although rare autopsy cases reported COVID-19 related myocardial inflammation, the origin of Tnc elevation is unknown to date. Several cardiac causes, such as myocarditis, non-ischemic myocardial injury (NIMI), or myocardial infarction (MI) may lead to Tnc kinetic. Our work will test the hypothesis that during SARS-Cov2 infection, the elevation of cardiac biomarkers could be linked to the occurrence of myocarditis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
273
Inclusion Criteria
  • COVID-19 positive patient hospitalized < 72 h after symptoms onset with troponin assessement.
Exclusion Criteria
  • patients hospitalized > 72h after symptom onset

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
BBiological dataCOVID positive and Troponin negative
AClinical dataCOVID positive and Troponin positive
ABiological dataCOVID positive and Troponin positive
BClinical dataCOVID positive and Troponin negative
Primary Outcome Measures
NameTimeMethod
characterize the myocardial damage associated with CoV-2 SARS infectionThrough study completion, an average of 2 years

Myocardtitis diagnosis in patients COVID+ and troponin+

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chu Dijon Bourgogne

🇫🇷

Dijon, France

© Copyright 2025. All Rights Reserved by MedPath